Effect of 2 vs 3 Doses of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease: A Population-based Propensity Matched Analysis

Keyphrases

• Inflammatory Bowel Disease 100%
• Population-based 100%
• Propensity-matched Analysis 100%
• COVID-19 Vaccine 100%
• Confidence Interval 50%
• Unvaccinated 40%
• Low Risk 30%
• COVID-19 Risk 30%
• Vaccinated Patients 30%
• Severe COVID-19 Outcomes 30%
• Hospitalization 20%
• 2-dose 20%
• Adjusted Dose 20%
• Propensity Score Matching 20%
• Hospitalization Risk 10%
• Retrospective Cohort Study 10%
• Acute Kidney Injury 10%
• Intubation 10%
• COVID-19 10%
• Multi-institutional Database 10%
• Intensive Care Unit Care 10%
• Third Dose 10%
• BNT162b2 10%
• MRNA-1273 10%
• Breakthrough Infection 10%
• TriNetX 10%

Medicine and Dentistry

• Patient with Inflammatory Bowel Disease 100%
• COVID-19 Vaccine 100%
• COVID-19 77%
• Propensity Score Matching 22%
• Infection 11%
• Retrospective Cohort Study 11%
• Intensive Care Unit 11%
• Acute Kidney Injury 11%
• Intubation 11%
• Drug Dose Reduction 11%
• Messenger RNA 11%
• Inflammatory Bowel Disease 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammatory Bowel Disease 100%
• COVID-19 Vaccine 100%
• Infection 10%
• Cohort Study 10%
• Acute Kidney Failure 10%
• Intubation 10%
• Messenger RNA 10%
• Administered Dose 10%